Indoles having anti-diabetic activity
Details for Australian Patent Application No. 2003262984 (hide)
International Classifications
Event Publications
11 December 2003 Complete Application Filed
Priority application(s): 60/440,672 17.01.03 US; 60/406,741 29.08.02 US
6 May 2004 Application Open to Public Inspection
Published as AU-B-2003262984
21 August 2008 Application Accepted
Published as AU-B-2003262984
9 October 2008 Application for Amendment
The nature of the amendment is as shown in the statement(s) filed 27 Aug 2008. Address for service in Australia - Spruson & Ferguson Level 35 St Martins Tower 31 Market Street Sydney NSW 2000
5 February 2009 Amendment Made
The nature of the amendment is as shown in the statement(s) filed 27 Aug 2008
5 February 2009 Standard Patent Sealed
21 January 2010 Amendment Made
The nature of the amendment is: Amend patentee name from Merck & Co., Inc. to Merck Sharp & Dohme Corp.
11 October 2012 Alteration of Name
The name of the patentee has been altered to Merck Sharp & Dohme Corp.
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser